(Q46588473)

23 December 2017

title

Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model (English)

1 reference

23 December 2017

1 reference

1 reference

1 reference

3

1 reference

23 December 2017

Elaine Del Bel

object named as

Elaine Del Bel

6

0 references

author name string

Marcio Lazzarini

1

1 reference

23 December 2017

Sabine Martin

2

1 reference

23 December 2017

Rita Raisman Vozari

4

1 reference

23 December 2017

Walter Stühmer

5

1 reference

23 December 2017

publication date

17 April 2013

1 reference

23 December 2017

published in

Glia

1 reference

23 December 2017

volume

61

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1084-1100

1 reference

23 December 2017

Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Dynamic signaling between astrocytes and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Cytotoxicity of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Relation Between Lipophilicity and Pharmacological Behavior of Minocycline, Doxycycline, Tetracycline, and Oxytetracycline in Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Classic and new animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Clinical potential of minocycline for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Quest for selectivity in inhibition of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Blockade of phencyclidine-induced effects by a nitric oxide donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Glutathione peroxidase, glial cells and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Neuroprotection by tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Microglia biology in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Transcriptional activation by tetracyclines in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Neurodegeneration or neuroprotection: the pivotal role of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Conditional RNAi in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Central and peripheral minocycline suppresses motor activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Clinical trials of neuroprotection for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Pharmacokinetic studies on minocycline in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Inducible and reversible gene expression with the rtTA system for the study of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The role of the immune system in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The role of astroglia on the survival of dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Neuroscience. The dark side of glia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

New roles for astrocytes: Regulation of synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Imaging of microglia in patients with neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Astrocytes and Therapeutics for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Doxycycline reduces early neurologic impairment after cerebral arterial air embolism in the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Fiji: an open-source platform for biological-image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Glia cell number modulates sensitivity to MPTP in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline and doxycycline are not beneficial in a model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Safety of doxycycline and minocycline: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Does orally administered doxycycline reach the tear film?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Tetracycline-controlled genetic switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

A novel conditional knockout strategy applied to serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline as a neuroprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline: neuroprotective mechanisms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Effect of doxycycline on pre-menstrual syndrome: a double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline delays disease onset and mortality in a transgenic model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The role of glial cells in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline enhances MPTP toxicity to dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

The promise of minocycline in neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

Microglial response to 6-hydroxydopamine-induced substantia nigra lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Trophic interactions between astroglial cells and hippocampal neurons in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Suppression of human neutrophil functions by tetracyclines

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Glial cell inhibition of neurons by release of ATP

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Maintenance of neuronal glutathione by glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22496

7 January 2021

Identifiers

DOI

10.1002/GLIA.22496

1 reference

23 December 2017

1 reference

23 December 2017